You can buy or sell IMV and other stocks, options, ETFs, and crypto commission-free!
IMV, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of cancer immunotherapies and infectious disease vaccines. The firm's patented platform, DepoVax, provides controlled and prolonged exposure of antigens and adjuvant to the immune system. Read More The company was founded by Warwick Kimmins and Brian E. Lowe on March 28, 2000 and is headquartered in Dartmouth, Canada.
Dartmouth, Nova Scotia
52 Week High
52 Week Low
Expected Nov 6, Pre-Market